Skip to main content
Premium Trial:

Request an Annual Quote

Celemics, Strand Life Sciences Partner on Integrated Platform for NGS Analysis

NEW YORK – Celemics, a Korean manufacturer of targeted capture kits for next-generation sequencing, is combining its bioinformatics pipeline with analytics technology from Strand Life Sciences to help researchers go from sample to report using a single technology platform.

Under terms of the partnership, Bengaluru, India-based Strand Life Sciences will integrate the Celemics pipeline into its StrandOmics tertiary analysis platform. This integrated offering will include assay-specific variant filters to provide "guaranteed" clinical-grade data compliance for researchers in cancer and rare diseases, according to the companies.

"With our … track record of running NGS labs as well as interpretation support for genetic tests, we are excited to partner with Celemics to help bring their cancer, inherited cancer, and rare disease panels to the market," Strand Life Sciences CEO Ramesh Hariharan said in a statement.

"[Strand's] expertise in the engineering of NGS systems and long track record with the instrument and diagnostic companies will be valuable in accelerating our path to market integration," added Hyoki Kim, cofounder and CEO of Seoul, South Korea-based Celemics.

The Scan

University of Michigan President Fired

Mark Schlissel, the president of the University of Michigan, has been fired after an investigation into allegations he had an affair with a subordinate, the Washington Post reports.

Recommendation to Drop Charges

The Wall Street Journal says federal prosecutors recommended charges against MIT's Gang Chen, who was caught up by the China Initiative, be dropped.

Mix 'Em Together

The Guardian reports Moderna is planning to have a combination SARS-CoV-2, influenza, and RSV vaccine by the 2023 flu season.

PNAS Papers on Earth BioGenome Project, SETX Knockouts, Pig Model of Cystic Fibrosis

In PNAS this week: Earth BioGenome Project reports progress, analysis of cells missing the progressive neurodegenerative disease-linked SETX gene, and more.